{"entity":{"type":"insider","cik":"0001824633","url":"/insider/0001824633","json_url":"/insider/0001824633.json","name":"Vaddi Krishna","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":10,"first":"2022-12-21","last":"2025-03-27","span_basis":"filed_date"},"name_variants":[{"name":"Vaddi Krishna","source":"filing","n_filings":10,"first_seen":"2022-12-21","last_seen":"2025-03-27"}],"transactions":[{"id":4082681,"accession":"0001562180-25-002778","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-002778","line_url":"/filing/0001562180-25-002778#line-1","is_derivative":false,"issuer_cik":"0001678660","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001678660","owner_cik":"0001824633","owner_name":"Vaddi Krishna","owner_url":"/insider/0001824633","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":675000.0,"shares_display":"675,000","price_per_share":0.6925,"price_display":"0.69","price_state":"stated","total_value":467437.5,"total_display":"467,437.50","shares_owned_after":1999296.0,"shares_owned_after_display":"1,999,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-25","filed_date":"2025-03-27","scope":"insider"},{"id":4894898,"accession":"0001562180-25-002697","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-002697","line_url":"/filing/0001562180-25-002697#line-2","is_derivative":false,"issuer_cik":"0001678660","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001678660","owner_cik":"0001824633","owner_name":"Vaddi Krishna","owner_url":"/insider/0001824633","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.7306,"price_display":"0.73","price_state":"stated","total_value":10959.0,"total_display":"10,959.00","shares_owned_after":1324296.0,"shares_owned_after_display":"1,324,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-21","filed_date":"2025-03-24","scope":"insider"},{"id":4894891,"accession":"0001562180-25-002697","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-002697","line_url":"/filing/0001562180-25-002697#line-1","is_derivative":false,"issuer_cik":"0001678660","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001678660","owner_cik":"0001824633","owner_name":"Vaddi Krishna","owner_url":"/insider/0001824633","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5416.0,"shares_display":"5,416","price_per_share":0.7294,"price_display":"0.73","price_state":"stated","total_value":3950.4304,"total_display":"3,950.43","shares_owned_after":1309296.0,"shares_owned_after_display":"1,309,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-24","scope":"insider"},{"id":5051785,"accession":"0001562180-25-002541","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-002541","line_url":"/filing/0001562180-25-002541#line-2","is_derivative":false,"issuer_cik":"0001678660","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001678660","owner_cik":"0001824633","owner_name":"Vaddi Krishna","owner_url":"/insider/0001824633","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9106.0,"shares_display":"9,106","price_per_share":0.7499,"price_display":"0.75","price_state":"stated","total_value":6828.5894,"total_display":"6,828.59","shares_owned_after":1303880.0,"shares_owned_after_display":"1,303,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-18","scope":"insider"},{"id":5051777,"accession":"0001562180-25-002541","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-002541","line_url":"/filing/0001562180-25-002541#line-1","is_derivative":false,"issuer_cik":"0001678660","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001678660","owner_cik":"0001824633","owner_name":"Vaddi Krishna","owner_url":"/insider/0001824633","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29999.0,"shares_display":"29,999","price_per_share":0.7544,"price_display":"0.75","price_state":"stated","total_value":22631.2456,"total_display":"22,631.25","shares_owned_after":1294774.0,"shares_owned_after_display":"1,294,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-14","filed_date":"2025-03-18","scope":"insider"},{"id":4650694,"accession":"0001562180-25-002392","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-002392","line_url":"/filing/0001562180-25-002392#line-2","is_derivative":false,"issuer_cik":"0001678660","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001678660","owner_cik":"0001824633","owner_name":"Vaddi Krishna","owner_url":"/insider/0001824633","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.7164,"price_display":"0.72","price_state":"stated","total_value":35820.0,"total_display":"35,820.00","shares_owned_after":1264775.0,"shares_owned_after_display":"1,264,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-13","filed_date":"2025-03-14","scope":"insider"},{"id":4650690,"accession":"0001562180-25-002392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-002392","line_url":"/filing/0001562180-25-002392#line-1","is_derivative":false,"issuer_cik":"0001678660","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001678660","owner_cik":"0001824633","owner_name":"Vaddi Krishna","owner_url":"/insider/0001824633","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":47500.0,"shares_display":"47,500","price_per_share":0.7104,"price_display":"0.71","price_state":"stated","total_value":33744.0,"total_display":"33,744.00","shares_owned_after":1214775.0,"shares_owned_after_display":"1,214,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-14","scope":"insider"},{"id":5091735,"accession":"0001562180-25-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-000031","line_url":"/filing/0001562180-25-000031#line-1","is_derivative":false,"issuer_cik":"0001678660","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001678660","owner_cik":"0001824633","owner_name":"Vaddi Krishna","owner_url":"/insider/0001824633","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.2087,"price_display":"1.21","price_state":"stated","total_value":6043.5,"total_display":"6,043.50","shares_owned_after":142553.0,"shares_owned_after_display":"142,553","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-31","filed_date":"2025-01-03","scope":"insider"},{"id":4865430,"accession":"0001562180-25-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-000008","line_url":"/filing/0001562180-25-000008#line-1","is_derivative":false,"issuer_cik":"0001678660","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001678660","owner_cik":"0001824633","owner_name":"Vaddi Krishna","owner_url":"/insider/0001824633","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":12000.0,"total_display":"12,000.00","shares_owned_after":137553.0,"shares_owned_after_display":"137,553","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-30","filed_date":"2025-01-02","scope":"insider"},{"id":2092094,"accession":"0001562180-24-008531","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-008531","line_url":"/filing/0001562180-24-008531#line-2","is_derivative":false,"issuer_cik":"0001678660","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001678660","owner_cik":"0001824633","owner_name":"Vaddi Krishna","owner_url":"/insider/0001824633","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6888.0,"shares_display":"6,888","price_per_share":0.8879,"price_display":"0.89","price_state":"stated","total_value":6115.8552,"total_display":"6,115.86","shares_owned_after":127553.0,"shares_owned_after_display":"127,553","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-19","filed_date":"2024-12-20","scope":"insider"},{"id":2092092,"accession":"0001562180-24-008531","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-008531","line_url":"/filing/0001562180-24-008531#line-1","is_derivative":false,"issuer_cik":"0001678660","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001678660","owner_cik":"0001824633","owner_name":"Vaddi Krishna","owner_url":"/insider/0001824633","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.9321,"price_display":"0.93","price_state":"stated","total_value":93210.0,"total_display":"93,210.00","shares_owned_after":1167275.0,"shares_owned_after_display":"1,167,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-18","filed_date":"2024-12-20","scope":"insider"},{"id":8170655,"accession":"0001562180-23-004517","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-23-004517","line_url":"/filing/0001562180-23-004517#line-2","is_derivative":false,"issuer_cik":"0001678660","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001678660","owner_cik":"0001824633","owner_name":"Vaddi Krishna","owner_url":"/insider/0001824633","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":5.31,"price_display":"5.31","price_state":"stated","total_value":4779.0,"total_display":"4,779.00","shares_owned_after":1067275.0,"shares_owned_after_display":"1,067,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-25","filed_date":"2023-05-26","scope":"insider"},{"id":8170651,"accession":"0001562180-23-004517","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-004517","line_url":"/filing/0001562180-23-004517#line-1","is_derivative":false,"issuer_cik":"0001678660","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001678660","owner_cik":"0001824633","owner_name":"Vaddi Krishna","owner_url":"/insider/0001824633","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.0114,"price_display":"5.01","price_state":"stated","total_value":5011.4,"total_display":"5,011.40","shares_owned_after":1066375.0,"shares_owned_after_display":"1,066,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-24","filed_date":"2023-05-26","scope":"insider"},{"id":8038917,"accession":"0001562180-23-004474","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-004474","line_url":"/filing/0001562180-23-004474#line-1","is_derivative":false,"issuer_cik":"0001678660","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001678660","owner_cik":"0001824633","owner_name":"Vaddi Krishna","owner_url":"/insider/0001824633","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11856.0,"shares_display":"11,856","price_per_share":5.63,"price_display":"5.63","price_state":"stated","total_value":66749.28,"total_display":"66,749.28","shares_owned_after":1065375.0,"shares_owned_after_display":"1,065,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-23","filed_date":"2023-05-25","scope":"insider"},{"id":6433565,"accession":"0001562180-22-008404","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-22-008404","line_url":"/filing/0001562180-22-008404#line-1","is_derivative":false,"issuer_cik":"0001678660","issuer_name":"Prelude Therapeutics Inc","issuer_ticker":"PRLD","issuer_name_source":null,"issuer_url":"/issuer/0001678660","owner_cik":"0001824633","owner_name":"Vaddi Krishna","owner_url":"/insider/0001824633","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19188.0,"shares_display":"19,188","price_per_share":5.1306,"price_display":"5.13","price_state":"stated","total_value":98445.9528,"total_display":"98,445.95","shares_owned_after":120665.0,"shares_owned_after_display":"120,665","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-21","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":15,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001678660","name":"Prelude Therapeutics Inc","url":"/issuer/0001678660","role":"Director, Officer (CEO)","n_filings":10,"first_seen":"2022-12-21","last_seen":"2025-03-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001824633","retrieved_at":"2026-08-21T08:05:29+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}